|Salary:||£38,826 per annum, including London Weighting Allowance|
|Placed On:||17th November 2021|
|Closes:||9th December 2021|
Salary: £38,826 per annum, including London Weighting Allowance
Building and Campus: David Goldberg Centre, Denmark Hill Campus
Dr. Huajie Jin; +44 (0)20 7848 0878 / firstname.lastname@example.org
Hiring manager/s: Vanessa Frederick, Liam Morton
We are looking to recruit an excellent, self-motivated health economist to undertake decision-analytic modelling and trial-based economic evaluations in the areas of breast and cervical cancer screening, renal medicine, and schizophrenia. This role requires economic modelling expertise, as well as competence in the technical software needed to undertake such modelling (e.g., Excel, R, TreeAge or Simul8).
Projects the postholder will work on include:
(1) The Prospects trial (https://medphys.royalsurrey.nhs.uk/prospects/). A 7-year multi-centre clinical trial which aims to explore the cost-effectiveness of breast cancer screening using digital breast tomosynthesis. The postholder will conduct an interim budget impact analysis and adapt an existing economic model for breast cancer screening.
(2) The STARRT-AKI trial (https://www.thebottomline.org.uk/summaries/icm/starrt-aki/). A 7-year multinational clinical trial which aims to compare the cost-effectiveness of accelerated initiation of renal replacement therapy compared to standard initiation in critically ill patients with severe acute kidney injury. The postholder will analyse the trial data, observational data and other relevant databases (such as Hospital Episode Statistics (HES) data and the Renal registry) to support the development of a de novo discrete event simulation (DES) model.
(3) The YouScreen trial (https://www.eastlondonhcp.nhs.uk/aboutus/youscreen.htm). A pragmatic implementation feasibility clinical trial which aims to compare the cost-effectiveness of HPV self-sampling versus no self-sampling for women aged 25-64 years who are overdue cervical screening by at least 6 months (i.e., non-attenders). The postholder will help to analyse the trial data and develop/adapt an economic model for cervical cancer screening.
(4) The PAT trial (https://fundingawards.nihr.ac.uk/award/NIHR200756). This study aims to compare the cost-effectiveness of a pharmacogenetics test to predict psychotic patients’ response to antipsychotic treatment versus no test based on big data collected from CRIS (https://www.maudsleybrc.nihr.ac.uk/facilities/clinical-record-interactive-search-cris/). The postholder will help to analyse the trial data and adapt an existing whole disease model for schizophrenia.
The postholder will work under the supervision of Dr Huajie Jin and Professor Sarah Byford. The role will be based within King’s Health Economics (KHE) (https://www.kcl.ac.uk/research/khe) which is situated at the Denmark Hill campus. The postholder will have the opportunity to join a thriving health economics research group with 25 years of experience undertaking health economic evaluations in collaboration with clinical collaborators across the UK and internationally. Candidates who are interested in doing a part-time PhD alongside their job are welcome.
This post will be fixed term until 30 September 2024.
This is a full-time post - 100% full time equivalent. Job share, part-time and flexible working will be considered.
Type / Role: